These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35945508)

  • 41. White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.
    Joki H; Higashiyama Y; Nakae Y; Kugimoto C; Doi H; Kimura K; Kishida H; Ueda N; Nakano T; Takahashi T; Koyano S; Takeuchi H; Tanaka F
    J Neurol Sci; 2018 Feb; 385():99-104. PubMed ID: 29406924
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort.
    van Steenoven I; Aarsland D; Weintraub D; Londos E; Blanc F; van der Flier WM; Teunissen CE; Mollenhauer B; Fladby T; Kramberger MG; Bonanni L; Lemstra AW;
    J Alzheimers Dis; 2016 Aug; 54(1):287-95. PubMed ID: 27567832
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
    Beyer MK; Larsen JP; Aarsland D
    Neurology; 2007 Aug; 69(8):747-54. PubMed ID: 17709706
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body disease.
    Malek-Ahmadi M; Beach TG; Zamrini E; Adler CH; Sabbagh MN; Shill HA; Jacobson SA; Belden CM; Caselli RJ; Woodruff BK; Rapscak SZ; Ahern GL; Shi J; Caviness JN; Driver-Dunckley E; Mehta SH; Shprecher DR; Spann BM; Tariot P; Davis KJ; Long KE; Nicholson LR; Intorcia A; Glass MJ; Walker JE; Callan M; Curry J; Cutler B; Oliver J; Arce R; Walker DG; Lue LF; Serrano GE; Sue LI; Chen K; Reiman EM
    PLoS One; 2019; 14(6):e0217566. PubMed ID: 31237877
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent advances in Lewy body dementia: A comprehensive review.
    Prasad S; Katta MR; Abhishek S; Sridhar R; Valisekka SS; Hameed M; Kaur J; Walia N
    Dis Mon; 2023 May; 69(5):101441. PubMed ID: 35690493
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased expression of pathological markers in Parkinson's disease dementia post-mortem brains compared to dementia with Lewy bodies.
    Tu H; Zhang ZW; Qiu L; Lin Y; Jiang M; Chia SY; Wei Y; Ng ASL; Reynolds R; Tan EK; Zeng L
    BMC Neurosci; 2022 Jan; 23(1):3. PubMed ID: 34983390
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Locus Coeruleus Pathology Indicates a Continuum of Lewy Body Dementia.
    Tilley BS; Patel SR; Goldfinger MH; Pearce RKB; Gentleman SM
    J Parkinsons Dis; 2021; 11(4):1641-1650. PubMed ID: 34334423
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials.
    Goldman JG; Forsberg LK; Boeve BF; Armstrong MJ; Irwin DJ; Ferman TJ; Galasko D; Galvin JE; Kaufer D; Leverenz J; Lippa CF; Marder K; Abler V; Biglan K; Irizarry M; Keller B; Munsie L; Nakagawa M; Taylor A; Graham T
    Alzheimers Res Ther; 2020 Oct; 12(1):137. PubMed ID: 33121510
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Systematic review of the efficacy of non-pharmacological interventions in people with Lewy body dementia.
    Morrin H; Fang T; Servant D; Aarsland D; Rajkumar AP
    Int Psychogeriatr; 2018 Mar; 30(3):395-407. PubMed ID: 28988547
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.
    Sierra M; Gelpi E; Martí MJ; Compta Y
    Neuropathol Appl Neurobiol; 2016 Aug; 42(5):451-62. PubMed ID: 26810462
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Consecutive sessions of transcranial direct current stimulation do not remediate visual hallucinations in Lewy body dementia: a randomised controlled trial.
    Elder GJ; Colloby SJ; Firbank MJ; McKeith IG; Taylor JP
    Alzheimers Res Ther; 2019 Jan; 11(1):9. PubMed ID: 30658705
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Erratum.
    Mult Scler; 2016 Oct; 22(12):NP9-NP11. PubMed ID: 26041800
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A soluble tau fragment generated by caspase-2 is associated with dementia in Lewy body disease.
    Smith BR; Nelson KM; Kemper LJ; Leinonen-Wright K; Petersen A; Keene CD; Ashe KH
    Acta Neuropathol Commun; 2019 Jul; 7(1):124. PubMed ID: 31362787
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical outcomes and treatment patterns of older adults with dementia-related psychosis by dementia type in the United States.
    Forns J; Danysh HE; McQuay LJ; Turner ME; Dempsey C; Anthony MS; Demos G; Layton JB
    BMC Geriatr; 2022 Oct; 22(1):784. PubMed ID: 36203129
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.
    Walker L; McAleese KE; Thomas AJ; Johnson M; Martin-Ruiz C; Parker C; Colloby SJ; Jellinger K; Attems J
    Acta Neuropathol; 2015 May; 129(5):729-48. PubMed ID: 25758940
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of assessment toolkits for improving the diagnosis of the Lewy body dementias: feasibility study within the DIAMOND Lewy study.
    Thomas AJ; Taylor JP; McKeith I; Bamford C; Burn D; Allan L; O'Brien J
    Int J Geriatr Psychiatry; 2017 Dec; 32(12):1280-1304. PubMed ID: 27928840
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pentagon drawing and neuropsychological performance in Dementia with Lewy Bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia.
    Cormack F; Aarsland D; Ballard C; Tovée MJ
    Int J Geriatr Psychiatry; 2004 Apr; 19(4):371-7. PubMed ID: 15065231
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prodromal dementia with Lewy bodies.
    Fujishiro H; Nakamura S; Sato K; Iseki E
    Geriatr Gerontol Int; 2015 Jul; 15(7):817-26. PubMed ID: 25690399
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies.
    Burn DJ; Rowan EN; Allan LM; Molloy S; O'Brien JT; McKeith IG
    J Neurol Neurosurg Psychiatry; 2006 May; 77(5):585-9. PubMed ID: 16614017
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cortical Lewy bodies and Aβ burden are associated with prevalence and timing of dementia in Lewy body diseases.
    Ruffmann C; Calboli FC; Bravi I; Gveric D; Curry LK; de Smith A; Pavlou S; Buxton JL; Blakemore AI; Takousis P; Molloy S; Piccini P; Dexter DT; Roncaroli F; Gentleman SM; Middleton LT
    Neuropathol Appl Neurobiol; 2016 Aug; 42(5):436-50. PubMed ID: 26527105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.